249 related articles for article (PubMed ID: 18782113)
1. Specific IgE serum concentration is associated with symptom severity in children with seasonal allergic rhinitis.
Rolinck-Werninghaus C; Keil T; Kopp M; Zielen S; Schauer U; von Berg A; Wahn U; Hamelmann E;
Allergy; 2008 Oct; 63(10):1339-44. PubMed ID: 18782113
[TBL] [Abstract][Full Text] [Related]
2. The co-seasonal application of anti-IgE after preseasonal specific immunotherapy decreases ocular and nasal symptom scores and rescue medication use in grass pollen allergic children.
Rolinck-Werninghaus C; Hamelmann E; Keil T; Kulig M; Koetz K; Gerstner B; Kuehr J; Zielen S; Schauer U; Kamin W; Von Berg A; Hammermann J; Weinkauf B; Weidinger G; Stenglein S; Wahn U;
Allergy; 2004 Sep; 59(9):973-9. PubMed ID: 15291906
[TBL] [Abstract][Full Text] [Related]
3. [Seasonal variations of serum-IgE and potential impact on dose-calculation of omalizumab (rhuMab-E25, anti-IgE)].
Beeh KM; Beier J; Buhl R
Pneumologie; 2004 Aug; 58(8):546-51. PubMed ID: 15293167
[TBL] [Abstract][Full Text] [Related]
4. Effect of anti-immunoglobulin E on nasal inflammation in patients with seasonal allergic rhinoconjunctivitis.
Bez C; Schubert R; Kopp M; Ersfeld Y; Rosewich M; Kuehr J; Kamin W; Berg AV; Wahu U; Zielen S
Clin Exp Allergy; 2004 Jul; 34(7):1079-85. PubMed ID: 15248853
[TBL] [Abstract][Full Text] [Related]
5. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
Kopp MV; Hamelmann E; Zielen S; Kamin W; Bergmann KC; Sieder C; Stenglein S; Seyfried S; Wahn U;
Clin Exp Allergy; 2009 Feb; 39(2):271-9. PubMed ID: 19016798
[TBL] [Abstract][Full Text] [Related]
6. Re-treatment with omalizumab at one year interval for Japanese cedar pollen-induced seasonal allergic rhinitis is effective and well tolerated.
Ogino S; Nagakura T; Okubo K; Sato N; Takahashi M; Ishikawa T
Int Arch Allergy Immunol; 2009; 149(3):239-45. PubMed ID: 19218816
[TBL] [Abstract][Full Text] [Related]
7. Omalizumab (Xolair) in children with seasonal allergic rhinitis: leukotriene release as a potential in vitro parameter to monitor therapeutic effects.
Kopp MV; Stenglein S; Kamin W; Friedrichs F; von Berg A; Zielen S; Hamelmann E; Wahn U; Kuehr J
Pediatr Allergy Immunol; 2007 Sep; 18(6):523-7. PubMed ID: 17680911
[TBL] [Abstract][Full Text] [Related]
8. Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitis.
Adelroth E; Rak S; Haahtela T; Aasand G; Rosenhall L; Zetterstrom O; Byrne A; Champain K; Thirlwell J; Cioppa GD; Sandström T
J Allergy Clin Immunol; 2000 Aug; 106(2):253-9. PubMed ID: 10932067
[TBL] [Abstract][Full Text] [Related]
9. The effect of anti-IgE treatment on in vitro leukotriene release in children with seasonal allergic rhinitis.
Kopp MV; Brauburger J; Riedinger F; Beischer D; Ihorst G; Kamin W; Zielen S; Bez ; Friedrichs F; Von Berg A; Gerhold K; Hamelmann E; Hultsch ; Kuehr J
J Allergy Clin Immunol; 2002 Nov; 110(5):728-35. PubMed ID: 12417881
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of specific IgE, soluble interleukin-2 receptor, and soluble intercellular adhesion molecule-1 in seasonal allergic rhinitis.
Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Ohno Y; Masamoto T; Sakamoto H; Kato A; Washio Y; Hayashi M
Ann Allergy Asthma Immunol; 1997 Sep; 79(3):213-20. PubMed ID: 9305226
[TBL] [Abstract][Full Text] [Related]
11. Transient impact of omalizumab in pollen allergic patients undergoing specific immunotherapy.
Kopp MV; Hamelmann E; Bendiks M; Zielen S; Kamin W; Bergmann KC; Klein C; Wahn U;
Pediatr Allergy Immunol; 2013 Aug; 24(5):427-33. PubMed ID: 23799935
[TBL] [Abstract][Full Text] [Related]
12. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
[TBL] [Abstract][Full Text] [Related]
13. Seasonal idiopathic rhinitis with local inflammatory response and specific IgE in absence of systemic response.
Rondón C; Doña I; López S; Campo P; Romero JJ; Torres MJ; Mayorga C; Blanca M
Allergy; 2008 Oct; 63(10):1352-8. PubMed ID: 18782115
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis.
Kuehr J; Brauburger J; Zielen S; Schauer U; Kamin W; Von Berg A; Leupold W; Bergmann KC; Rolinck-Werninghaus C; Gräve M; Hultsch T; Wahn U
J Allergy Clin Immunol; 2002 Feb; 109(2):274-80. PubMed ID: 11842297
[TBL] [Abstract][Full Text] [Related]
15. Seasonal non-allergic rhinitis (SNAR)--a new disease entity? A clinical and immunological comparison between SNAR, seasonal allergic rhinitis and persistent non-allergic rhinitis.
Wedbäck A; Enbom H; Eriksson NE; Movérare R; Malcus I
Rhinology; 2005 Jun; 43(2):86-92. PubMed ID: 16008061
[TBL] [Abstract][Full Text] [Related]
16. Rhinitis symptoms caused by grass pollen are associated with elevated basophile allergen sensitivity and a larger grass-specific immunoglobulin E fraction.
Zidarn M; Košnik M; Silar M; Grahek A; Korošec P
Clin Exp Allergy; 2012 Jan; 42(1):49-57. PubMed ID: 22093044
[TBL] [Abstract][Full Text] [Related]
17. Omalizumab rapidly decreases nasal allergic response and FcepsilonRI on basophils.
Lin H; Boesel KM; Griffith DT; Prussin C; Foster B; Romero FA; Townley R; Casale TB
J Allergy Clin Immunol; 2004 Feb; 113(2):297-302. PubMed ID: 14767445
[TBL] [Abstract][Full Text] [Related]
18. Omalizumab is effective and safe in the treatment of Japanese cedar pollen-induced seasonal allergic rhinitis.
Okubo K; Ogino S; Nagakura T; Ishikawa T
Allergol Int; 2006 Dec; 55(4):379-86. PubMed ID: 17130680
[TBL] [Abstract][Full Text] [Related]
19. Serum leptin levels in patients with pollen-induced allergic rhinitis.
Ciprandi G; Filaci G; Negrini S; De Amici M; Fenoglio D; Marseglia G
Int Arch Allergy Immunol; 2009; 148(3):211-8. PubMed ID: 18849612
[TBL] [Abstract][Full Text] [Related]
20. Bahia grass pollen specific IgE is common in seasonal rhinitis patients but has limited cross-reactivity with Ryegrass.
Davies JM; Bright ML; Rolland JM; O'hehir RE
Allergy; 2005 Feb; 60(2):251-5. PubMed ID: 15647049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
